Coexpression of human somatostatin receptor-2 (SSTR2) and SSTR3 modulates antiproliferative signaling and apoptosis
Related Experiment Video
Updated: May 21, 2026

Three-Dimensional (3D) Tumor Spheroid Invasion Assay
Published on: May 1, 2015
1Faculty of Pharmaceutical Sciences, The University of British Columbia, Vancouver, BC, V6T 1Z3, Canada. ujkumar@mail.ubc.ca.
Background:
Somatostatin (SST) via five Gi coupled receptors namely SSTR1-5 is known to inhibit cell proliferation by cytostatic and cytotoxic mechanisms. Heterodimerization plays a crucial role in modulating the signal transduction pathways of SSTR subtypes. In the present study, we investigated human SSTR2/SSTR3 heterodimerization, internalization, MAPK signaling, cell proliferation and apoptosis in HEK-293 cells in response to SST and specific agonists for SSTR2 and SSTR3.
Results:
Although in basal conditions, SSTR2 and SSTR3 colocalize at the plasma membrane and exhibit heterodimerization, the cell surface distribution of both receptors decreased upon agonist activation and was accompanied by a parallel increase in intracellular colocalization. Receptors activation by SST and specific agonists significantly decreased cAMP levels in cotransfected cells in comparison to control. Agonist-mediated modulation of pERK1/2 was time and concentration-dependent, and pronounced in serum-deprived conditions. pERK1/2 was inhibited in response to SST; conversely receptor-specific agonist treatment caused inhibition at lower concentration and activation at higher concentration. Strikingly, ERK1/2 phosphorylation was sustained upon prolonged treatment with SST but not with receptor-specific agonists. On the other hand, SST and receptor-specific agonists modulated p38 phosphorylation time-dependently. The receptor activation in cotransfected cells exhibits Gi-dependent inhibition of cell proliferation attributed to increased PARP-1 expression and TUNEL staining, whereas induction of p21 and p27Kip1 suggests a cytostatic effect.
Conclusion:
Our study provides new insights in SSTR2/SSTR3 mediated signaling which might help in better understanding of the molecular interactions involving SSTRs in tumor biology.
Insights
Somatostatin receptors SSTR2 and SSTR3 heterodimerize and signal via Gi-dependent pathways. This interaction inhibits cell proliferation through cytostatic and cytotoxic mechanisms, offering insights into tumor biology.
Area of Science:
- Endocrinology
- Molecular Cell Biology
- Pharmacology
Background:
- Somatostatin (SST) inhibits cell proliferation via five G protein-coupled receptors (SSTR1-5).
- Receptor heterodimerization is critical for modulating SSTR signaling pathways.
- This study focuses on human SSTR2/SSTR3 heterodimerization and its downstream effects.
Purpose of the Study:
- To investigate human SSTR2/SSTR3 heterodimerization, internalization, and MAPK signaling.
- To examine the impact of SST and specific agonists on cell proliferation and apoptosis.
- To elucidate the signaling mechanisms of SSTR2/SSTR3 interactions.
Main Methods:
- HEK-293 cells were cotransfected with SSTR2 and SSTR3.
- Receptor localization, heterodimerization, and cAMP levels were assessed.
- MAPK signaling (ERK1/2, p38), cell proliferation, and apoptosis were analyzed.
Main Results:
- SSTR2 and SSTR3 heterodimerize at the plasma membrane and internalize upon agonist activation.
- SST and agonists decreased cAMP levels and modulated ERK1/2 and p38 phosphorylation.
- Gi-dependent inhibition of cell proliferation was observed, with increased PARP-1 and TUNEL staining, and induced p21/p27Kip1.
Conclusions:
- SSTR2/SSTR3 signaling involves Gi-dependent inhibition of proliferation.
- Mechanisms include cytostatic effects (p21/p27Kip1 induction) and cytotoxic effects (PARP-1, TUNEL).
- Findings offer insights into SSTR-mediated signaling in tumor biology.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation

